...
首页> 外文期刊>BMC Genomics >Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations
【24h】

Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations

机译:遗传模块和miRNome特性分析反映了来自不同解剖位置的内皮祖细胞的独特生物学特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Endothelial progenitor cells (EPCs) play a fundamental role in post-natal vascular repair, yet EPCs from different anatomic locations possess unique biological properties. The underlying mechanisms are unclear. Results EPCs from CB expressed abundant genes involved in cell cycle, hypoxia signalling and blood vessel development, correlating with the phenotypes that CB-EPCs proliferated more rapidly, migrated faster, and formed tubule structure more efficiently. smRNA-seq further deciphered miRNome patterns in EPCs isolated from CB or PB: 54 miRNAs were enriched in CB-EPCs, while another 50 in PB-EPCs. Specifically, CB-EPCs expressed more angiogenic miRNAs such as miR-31, while PB-EPCs possessed more tumor suppressive miRNAs including miR-10a. Knocking down miR-31 levels in CB-EPCs suppressed cell migration and microtubule formation, while overexpressing miR-31 in PB-EPCs helped to recapitulate some of CB-EPC functions. Conclusions Our results show the foundation for a more detailed understanding of EPCs from different anatomic sources. Stimulating the expression of angiogenic microRNAs or genes in EPCs of low activity (such as those from patients with cardiovascular diseases) might allow the development of novel therapeutic strategies.
机译:背景内皮祖细胞(EPC)在产后血管修复中起着基本作用,但是来自不同解剖位置的EPC具有独特的生物学特性。潜在的机制尚不清楚。结果来自CB的EPCs表达丰富的基因,参与细胞周期,缺氧信号传导和血管发育,与CB-EPCs增殖更快,迁移更快并更有效地形成肾小管结构的表型相关。从CB或PB分离的EPC中,smRNA-seq进一步破译了miRNome模式:在CB-EPC中富集了54个miRNA,而在PB-EPC中又富集了50个miRNA。具体而言,CB-EPC表达更多的血管生成性miRNA,例如miR-31,而PB-EPC具有更多的肿瘤抑制性miRNA,包括miR-10a。降低CB-EPC中的miR-31水平可抑制细胞迁移和微管形成,而在PB-EPC中过表达miR-31有助于概括一些CB-EPC功能。结论我们的结果为更详细地了解来自不同解剖来源的EPC提供了基础。刺激低活性的EPC(例如来自心血管疾病患者的EPC)中的血管生成性microRNA或基因的表达可能允许开发新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号